The deal valued at up to $500 million grants Bio Usawa exclusive, worldwide rights to use and sublicense the DynaShield™ technology across its portfolio and in third-party biologic and vaccine ...

Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Gemini™, a ...

The Pharma Wholesale and Distribution Market presents key opportunities such as leveraging cold chain logistics for specialty pharma growth, driven by demand for vaccines and biologics. Infrastructure ...

Designed specifically for bioreactor-scale workflows, the system reportedly requires less than 15 minutes of hands-on time.

Designed specifically for bioreactor-scale workflows, the Krakatoa (R) K500 requires less than 15 minutes of hands-on time and produces up to 500 liters in less than three hours. Two standard pod ...

Third-party logistics providers (3PLs) play a critical role in the pharma supply chain, being tasked with the management of ...

In the latest episode of The Top Line, Chris Hayden of Fierce Pharma sits down with Mary Lou Glotzbach, senior manager of drug delivery partnerships at Grand River Aseptic Manufacturing (GRAM). They ...

Nucleus Biologics launched the Krakatoa® K500, a pod-based, on-demand manufacturing system that produces 35–500L of media and ...